- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Gland Pharma Limited — Updates, 26-08-2025: Press Release
26-08-2025 | 11:56 am
26-08-2025 | 11:56 am
Gland Pharma received USFDA approval for Vasopressin 5% Dextrose Injection (RTU Vials) and tentative approval for another strength. The reference drug had US sales of approximately USD 45 million, indicating a significant market opportunity for the company.
No comments yet. Be the first to comment!